Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer
      Biotech

      GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer

      January 3, 2025
      WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year
      Biotech

      WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year

      January 2, 2025
      A speckle of hope for cancer patients
      Biotech

      A speckle of hope for cancer patients

      January 2, 2025
      Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
      Biotech

      Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA

      January 1, 2025
      CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy
      Biotech

      CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

      January 1, 2025
      TCBP Provides Update on Acquisition Strategy and Current Targets
      Biotech

      TCBP Provides Update on Acquisition Strategy and Current Targets

      January 1, 2025
      TCBP Issues 25% Stock Dividend
      Biotech

      TCBP Issues 25% Stock Dividend

      December 31, 2024
      ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma
      Biotech

      ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

      December 31, 2024
      Save The Giraffes spearheads breakthroughs in reproductive science in wild giraffes
      Biotech

      Save The Giraffes spearheads breakthroughs in reproductive science in wild giraffes

      December 31, 2024
      IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors
      Biotech

      IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors

      December 30, 2024
      « 1 … 67 68 69 70 71 … 151 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026